AstraZeneca

AstraZeneca AZN Stock

$178.76   -1.925720%
Add to favorites
Market Cap
$277.24B
LOW - HIGH [24H]
$178.29 - $181.50
VOLUME [24H]
$2.26M
P/E Ratio
25.28
Earnings per share
$7.07
ISIN
US0463531089
Price   Prediction

AstraZeneca Price Chart

Sorry, that's all we've gotfor now...

AstraZeneca (AZN) stock price today is 178.76 USD on Tech Market Large (-1.93% on the day). Updated .

AstraZeneca AZN Financial and Trading Overview

AstraZeneca stock price 178.76 USD
Previous Close 184.02 USD
Open 181.25 USD
Bid 0 USD x 40000
Ask 0 USD x 30000
Day's Range 181.08 - 183.66 USD
52 Week Range 153.41 - 212.71 USD
Volume 2.36M USD
Avg. Volume 3.02M USD
Market Cap 282.69B USD
Beta (5Y Monthly) 0.155
PE Ratio (TTM) 25.780764
EPS (TTM) 7.07 USD
Forward Dividend & Yield 3.2 (1.76%)
Ex-Dividend Date August 7, 2026
1y Target Est 208.08 USD

AZN Valuation Measures

Enterprise Value 308.95B USD
Trailing P/E 25.780764
Forward P/E 16.106327
PEG Ratio (5 yr expected) 1.33
Price/Sales (ttm) 4.5313826
Price/Book (mrq) 5.4652033
Enterprise Value/Revenue 4.952
Enterprise Value/EBITDA 14.518

Trading Information

AstraZeneca Stock Price History

Beta (5Y Monthly) 0.155
52-Week Change 2.74%
S&P500 52-Week Change 12.07%
52 Week High 212.71 USD
52 Week Low 153.41 USD
50-Day Moving Average 169.23 USD
200-Day Moving Average 180.18 USD

AZN Share Statistics

Avg. Volume (3 month) 3.02M USD
Avg. Daily Volume (10-Days) 2.73M USD
Shares Outstanding 1.55B
Float 1.54B
Short Ratio 0.99
% Held by Insiders 0.052%
% Held by Institutions 67.08%
Shares Short 3.03M
Short % of Float 0.20%
Short % of Shares Outstanding 0.20%

Dividends & Splits

Trailing Annual Dividend Rate 3.23
Trailing Annual Dividend Yield 1.75%
5 Year Average Dividend Yield 204.00%
Payout Ratio 0.45380002
Last Split Factor 1:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 17.68%
Operating Margin (ttm) 25.80%
Gross Margin 81.78%
EBITDA Margin 34.11%

Management Effectiveness

Return on Assets (ttm) 8.58%
Return on Equity (ttm) 22.56%

Income Statement

Revenue (ttm) 62.38B USD
Revenue Per Share (ttm) 40.25 USD
Quarterly Revenue Growth (yoy) 6.70%
Gross Profit (ttm) 51.02B USD
EBITDA 21.28B USD
Net Income Avi to Common (ttm) 11.03B USD
Diluted EPS (ttm) 7.07
Quarterly Earnings Growth (yoy) 23.10%

Balance Sheet

Total Cash (mrq) 8.17B USD
Total Cash Per Share (mrq) 5.27 USD
Total Debt (mrq) 34.33B USD
Total Debt/Equity (mrq) 66.25 USD
Current Ratio (mrq) 1.006
Book Value Per Share (mrq) 33.351

Cash Flow Statement

Operating Cash Flow (ttm) 13.23B USD
Levered Free Cash Flow (ttm) 5.63B USD

Profile of AstraZeneca

Country United States
State N/A
City Cambridge
Address 1 Francis Crick Avenue
ZIP CB2 0AA
Phone 44 20 3749 5000
Website https://www.astrazeneca.com
Industry Drug Manufacturers - General
Sector(s) Healthcare
Full Time Employees 96100

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies for rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, USA, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of oral candidates; Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates; and Carterra, Inc. to advances lab-in-the-loop drug discovery through new scientific research collaboration. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is based in Cambridge, the United Kingdom.

Q&A For AstraZeneca Stock

What is a current AZN stock price?

AstraZeneca AZN stock price today per share is 178.76 USD.

How to purchase AstraZeneca stock?

You can buy AZN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for AstraZeneca?

The stock symbol or ticker of AstraZeneca is AZN.

Which industry does the AstraZeneca company belong to?

The AstraZeneca industry is Drug Manufacturers - General.

How many shares does AstraZeneca have in circulation?

The max supply of AstraZeneca shares is 1.55B.

What is AstraZeneca Price to Earnings Ratio (PE Ratio)?

AstraZeneca PE Ratio is 25.28429800 now.

What was AstraZeneca earnings per share over the trailing 12 months (TTM)?

AstraZeneca EPS is 7.07 USD over the trailing 12 months.

Which sector does the AstraZeneca company belong to?

The AstraZeneca sector is Healthcare.

AstraZeneca AZN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.12B USD — 24225.3 USD — 24538.78 USD — — 7.12B USD —
us US100 NDX US 27116.26 USD —
+0.42
1.39B USD — 26848.92 USD — 27236.12 USD — — 1.39B USD —
us US Tech-100 Equal Weighted NDXE US 9466.09 USD —
<0.01
— — 9403.06 USD — 9535.26 USD — — — —
us US Tech-100 Micro Index XND US 271.16 USD —
+0.42
— — 268.49 USD — 272.36 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us Stlmt ID US Tech 100 XQO US 16266.86 USD —
-0.45
— — 15738.2 USD — 16639.8 USD — — — —
us US Tech-100 Pre Market Indicator QMI US 27140.44 USD —
+0.51
— — 27123.38 USD — 27226.05 USD — — — —
us US Tech OMX CRD Global Sustainab QCRD US 1595.1 USD —
0
— — — — — — — — —
us Folksam OMXS60 Cap FMOMXS60CAP US 168.13 SEK 16.41 USD
0
— — — — — — — — —
se EXBIZ OMX Stockholm Benchmark S OMXSBSHARIA SE 1636.08 SEK 159.7 USD
—
— — — — — — — — —
us NYSE Arca Pharmaceutical Index DRG US 1343.1 USD —
-2.2
— — 1340.56 USD — 1373.02 USD — — — —
us NYSE Composite Index NYA US 23559.61 USD —
-1.06
— — 23530.84 USD — 23742.73 USD — — — —
se US Tech Nordea SmartBeta Momentu NQNDMOT SE 1246.3 SEK 121.65 USD
-0.83
— — 1244.39 SEK 121.47 USD 1263.05 SEK 123.29 USD — — —
us US Tech-100 Ex-Tech Sector NDXX US 5991.89 USD —
-0.07
— — 5973.31 USD — 6033.71 USD — — — —
us US Tech-100 ESG JPY Index NDXESG07 US 2910.45 JPY 17.95 USD
+0.55
— — 2876.81 JPY 17.74 USD 2924.17 JPY 18.03 USD — — —
us US Tech-100 Notional Net Total R XNDXNNR US 31625.93 USD —
+0.42
— — 31314.13 USD — 31765.72 USD — — — —
se VINX30 VINX30 SE — —
—
— — — — — — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech-100 PM Settlement Value XQC US 16331.98 USD —
+1.13
— — 16331.98 USD — 16331.98 USD — — — —
us US Tech-100 After Hours Indicato QIV US 27099.91 USD —
+0.36
— — 27079.3 USD — 27161.89 USD — — — —
$2.16T
Total marketcap
$70.37B
Total volume
BTC 57.95%   •   ETH 9.97%
Dominance
Select currency